Skip to main content
. 2018 Nov 19;22:307. doi: 10.1186/s13054-018-2221-8

Fig. 2.

Fig. 2

Etiology and clinical course of Pneumocystis pneumonia (PcP). a Percentage of patients with respect to clinical course of PcP including organ replacement therapies (ICU, intensive care unit; ECMO, extracorporeal membrane oxygenation; RRT, renal replacement therapies) and outcomes. b Hospital mortality in different clinical settings (gray area highlights overall mortality). c Percentage of ICU admission and d percentage of ICU mortality with immunosuppression with different etiologies. The gray area shows the total percentage independent from the etiology. SOT, solid organ transplant; ChTx, chemotherapy; IS/RD, immunosuppression/rheumatic disease